Brugada Syndrome Treatment Market : Increase in Government Prioritization of Drugs for Rare Disorders to Propel the Market Growth
Brugada syndrome is a life-threatening heart rhythm disorder. It causes a disruption of the normal rhythm in the heart's lower chambers. It can be caused by a mutation, most commonly of the SCN5A gene. In some cases, researchers are unable to identify the primary cause of Brugada syndrome. Adult men are frequently diagnosed with the syndrome as compared to women. However, young children and adolescents are diagnosed at the same rate.
View full press release